Labelling very low-risk conditions as cancers can cause unnecessary anxiety and lead to overtreatment.
Unfortunately, there is no net benefit-ometer for breast cancer screening.
Previously, a person would be diagnosed with high blood pressure if their systolic reading was 140mmHg. But it's recommended this threshold be lowered to 130mmHg, which will do more harm than good.
Since the 1980s, PSA tests have been used for the diagnosis and follow-up of prostate cancer. However, its use as a screening test for prostate cancer remains controversial.
Rates of spinal fusion surgery for back pain are on the rise. This is despite little evidence that it's an effective procedure and studies showing many will have revision surgery within ten years.
The majority of research suggests the benefits of mammography screening greatly outweigh the harms for women over age 40.
Australian health-care organisations are urging action on treatments of people who don't need them.
Two major studies cast doubt on the value of screening for prostate cancer, yet it continues regardless.
More of us are labelled as sick with the constantly changing diagnostic cut-offs for diseases. Now an international expert panel has drafted a list of things to consider before setting new thresholds.
Reducing health-care waste relating to unnecessary tests has been a major priority for researchers, governments and health services for decades. But how do we change the behaviour of doctors?
It's not necessarily the case children who are young for their year are being inappropriately diagnosed with ADHD. This is a simplistic analysis.
The drug's limited effectiveness and side-effects should cause potential users to rethink their purchase.
The creation of new “pre-conditions” is turning millions of people into patients across the globe.
Harm doesn’t just come in the form of side-effects or further testing. The "cons" of any treatment also include the costs, which can be financial, emotional, and the costs of the individual’s time.
This was the year of the health review – mental health care, Medicare, private health insurance, the pharmacy industry ... and the list goes on. But how much movement was there on policy?
The evidence suggests too much medicine is doing us harm, particularly when treating knee pain, back pain, chest pain and screening for prostate cancer.
To avoid ineffective treatments, we need a new way to identify and reduce questionable care. A new Grattan Institute report shows how to do it.
By forgetting that medicine postpones death rather than saving lives, we persuade ourselves it might somehow keep extending our life and come to view death as a failure of medicine.
While the extent of the problem is unclear, we know that hospitals doctors overuse diagnostic tests. Involving patients in decision-making may be one of the best options for improving the situation.
In October 2013, Catalyst broadcast a segment highly critical of statins, a class of drug used for lowering cholesterol.